Instadose Pharma

Instadose Pharma

Political movements have opened Cannabis for medical and recreational use. The result is a slowly shifting patchwork of regulations as many countries (and sometimes smaller jurisdictions) start to allow limited use and increasingly liberalize their stance.
Research / Cannabis Analysis Labs
Medical Marijuana State Programs
Dispensary
Processing: Hemp

About Instadose Pharma

Global leader in cannabis production & commercial distribution of Cannabinoid Oil

Leading the disruption of the global cannabis industry by turning cannabis and Cannabinoid Oil into an insurable commodity

Exclusive right and license to grow, cultivate, and process (for export and sale) medical pharmaceutical cannabis in the DRC

50-year partnerships with the newly elected DRC government & the SACCOS (the region's largest farming co-operative) - gives Instadose 1,000,000+ hectares (ha) of land in the aggregate for cannabis production & cultivation

Existing 5-year supply agreements for Cannabinoid Oil with leading global buyers generating USD$4.375B+ in revenue to Instadose

GMP Certified & pharmaceutically accredited with EU Pharmacopeia Standards

Talented and respected management team with proven track records in the cannabis, pharmaceutical, and capital markets space

Anticipated listing on North American and European stock exchanges

Team

Grant F Sanders
Chairman & CEO at Instadose Pharma Corp
Loren S. Greenspoon
Co-Founder & General Counsel